IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Opus Point Partners Management, LLC

Q4 2016 Holdings

Filed 2017-02-14 | 57 holdings | $12.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↑Shares% Portfolio
Spdr Series Trust(XBI)CallS&P BIOTECH78464A870$17.8K300,0000.1%
Charles RIV Labs Intl Inc(CRL)COM159864107$252.0K3,3032.1%
Acadia Pharmaceuticals Inc(ACAD)COM004225108$290.0K10,0422.4%
Agios Pharmaceuticals Inc(AGIO)COM00847X104$2.3M55,52419.3%
Biomarin Pharmaceutical Inc(BMRN)COM09061G101$2.6M31,57921.8%
Biogen Inc(BIIB)COM09062X103$3.1M10,87225.7%
Alnylam Pharmaceuticals Inc(ALNY)COM02043Q107$3.3M88,78427.7%
PreviousPage 2 of 2